Trial oversight and trial stopping

AB Antoine P Brézin
DM Dominique Monnet
FL François Lignereux
PR Pascal Rozot
LJ Lea Jilet
HA Hendy Abdoul
request Request a Protocol
ask Ask a question
Favorite

The primary analysis was realised in February 2022 on 1000 enrolled procedures. The sponsor and the scientific committee decided to stop the trial on March 2022 as the results demonstrated a significative diminution of CDE in AS group versus non-AS group (p<0.0001).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A